米国の骨粗鬆症市場

This research service covers the U.S. osteoporosis market from 2004-2014. Included are disease overviews, technology trends, total market revenue forecasts, market segment revenue forecasts, and market share analysis. The market is segmented by product class: bisphosphonates, selective estrogen receptor modulators, calcitonins, parathyroid hormones, and novel therapeutic approaches. Major market challenges, drivers, and restraints and identified and discussed.

Table of Contents

Executive Summary

• Introduction

Research Scope and Methodology

• Scope & Segmentation
• Research Methodology

Market Overview

• Market Engineering Measurements
• Disease Overview
• Treatment Options
• Patient Forecasts
• Industry Challenges
• Market Drivers
• Market Restraints

Product Analysis

• Bisphosphonates
• Selective Estrogen Receptor Modulators
• Calcitonins
• Parathyroid Hormones

Pipeline Analysis

• Bisphosphonates
• Selective Estrogen Receptor Modulators
• Calcitonins
• Parathyroid Hormones
• Novel Therapeutic Approaches

Competitive Analysis

• Competitive Structure

Forecasts and Trends

• Total Market
• Bisphosphonates
• Selective Estrogen Receptor Modulators
• Calcitonins
• Parathyroid Hormones
• Novel Therapeutic Approaches

Market Share Analysis

• Company Market Share
• Product Market Share

Decision Support Databases

• Male Population 65 Plus
• Female Population 65 Plus
• Percentage of Population 65 Plus
• Total Population 65 Plus
• U.S. Population with Osteoporosis